1. Scrip

Five Late-Breakers To Watch For At ASCO 2021

 
• By Alexandra Shimmings

This year’s American Society of Clinical Oncology meeting is set to take place virtually from 4-8 June, and while many abstracts have now been released for this year’s conference, we take a sneak peek at what is still under wraps, with five of the key late-breaking presentations due to be presented at the plenary session, with input from Biomedtracker and Datamonitor Healthcare.    

Cancer - DNA - test tube

A significant new commercial opportunity could open up for AstraZeneca PLC’s Lynparza (olaparib) on the back of the OlympiA study, the first numerical data from which will be presented in a plenary session at ASCO.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from ASCO

More from Conferences